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Abstract
Introduction: Bacterial meningitis is a complex, rapidly progressive disease in which neurological injury is caused
in part by the causative organism and in part by the host’s own inflammatory responses.
Case presentation: We present the case of a two-year-old Greek girl with pneumococcal meningitis and an
atypical curvilinear-like skin eruption, chronologically associated with cerebral vasculitis. A diffusion-weighted MRI
scan showed lesions with restricted diffusion, reflecting local areas of immunologically mediated necrotizing
vasculitis.
Conclusions: Atypical presentations of bacterial meningitis may occur, and they can be accompanied by serious
unexpected complications.
Introduction
Neurological injury in Streptococcus pneumoniae menin-
gitis can be due to meningeal inflammation, cerebral
edema, necrosis and intracranial hemorrhage. There is a
widely held belief that cerebral infarction after bacterial
meningitis is always caused by vasculitis; however, evi-
dence for this is weak. Vergouwen et al.h y p o t h e s i z e d
that diffuse cerebral intravascular coagulation is an addi-
tional explanation for cerebral infarction in patients with
pneumococcal meningitis [1]. At the molecular level, S.
pneumoniae cell walls have been shown to induce cere-
brovascular endothelial cells, microglia, and meningeal
inflammatory cells to release cytokines, chemokines and
reactive oxygen species [2]. These include tumor necro-
sis factor a, interleukins 1 and 6, platelet-activating fac-
tor, peroxynitrites, matrix metalloproteinases and
urokinase plasminogen activator. Release of such biopro-
ducts is believed to play a role in the development of
disseminated intravascular coagulation in the setting of
pneumococcal sepsis. To the best of our knowledge, we
present a previously-unreported association of an
exaggerated host response, as shown by the develop-
ment of vasculitis, with an unusual rash in a child with
pneumococcal meningitis.
Case presentation
A two-year-old Greek girl was referred to our Pediatric
Intensive Care Unit (PICU) with a two-day history of
fever (39.3°C), vomiting, reduced appetite for feeding
and seizures. A physical examination showed nuchal
rigidity, a decreased level of consciousness and multiple
erythematous, flat macules present on her hands and
the dorsal and plantar aspects of her feet (Figure 1), tak-
ing a curvilinear appearance (Figure 2A, B). Our patient
had an unremarkable medical history; she had not been
vaccinated for S. pneumoniae.
A complete blood cell count revealed 18,000 cells/μL
white blood cells (neutrophils 80%, leukocytes 17%), her
C-reactive protein serum level was 28.87 mg/dL, and
pronounced coagulation disturbances were detected
(prothrombin time: 15.4 seconds; activated partial
thromboplastin time: 33 seconds; international normal-
ized ratio: 1.38; fibrinogen: 375 mg/dL, D-dimers: 91.63
mg/dL). Results of a lumbar puncture showed white
blood cells at 40 cells/mm
3, a total protein content of
169 mg/dL and hypoglycorrhachia of 2 mg/dL. Gram-
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cocci in pairs. Two days after admission, blood and cer-
ebrospinal fluid cultures yielded pure growth of vanco-
mycin susceptible (MIC # 1 μg/mL, 25 mm) and
penicillin susceptible (MIC # 0.12 μg/mL) Streptococcus
pneumoniae. Serotype 23F was identified by PCR from
two blood samples and in the first sample of cerebrosp-
inal fluid (CSF). The same isolate was also cultured
from our patient’s throat. IgG subclasses were normal
and the results of an HIV test were negative. Due to the
lack of clinical improvement, an urgent diffusion-
weighted MRI scan was performed six days after admis-
sion. The MRI showed ill-defined hyperintense lesions
at the peri-ventricular and white matter, exhibiting
restricted diffusion (Figure 3).
Boluses of intravenous fluids, fresh frozen plasma
and intravenous dexamethasone (0.15 mg/kg) were
given, immediately followed by systematic administra-
tion of ceftriaxone (100 mg/kg/day) and vancomycin
(60 mg/kg/day). Due to persistent drowsiness and
further clinical deterioration, a second lumbar punc-
ture was taken. The results of this were 90 leukocytes/
mm
3, a glucose level of 36 mg/dL, and protein 124
mg/dL, whereas a further CSF culture did not reveal
any isolation. Aiming at better permeability through
the blood brain barrier, intravenous rifampicin (40 mg/
kg/day, MIC # 1 μg/mL, 27 mm) was added. Although
the responsible isolate was sensitive to the antibiotics
administered, our patient showed a slow clinical
response; consequently the combined antibiotic regi-
men was administered for a total of 14 days after ther-
apy initiation. Her fever and atypical rash started
resolving after the first week. Our patient made a full
neurological recovery, apart from bilateral hearing
impairment confirmed by brain stem response.
Figure 1 Multiple non-hemorrhagic erythematous flat macules
on the dorsal and plantar aspects of feet. B
A
Figure 2 Confluent elongated skin lesions (A, arrows) with
curvilinear projections (B, arrows) at the time of isolation of
Streptococcus pneumoniae in blood and cerebrospinal fluid.
Figure 3 MRI scan showing ill-defined hyperintense lesions at
the peri-ventricular and subcortical white matter (arrows) that
were identified shortly after the skin eruption and the
Streptococcus pneumoniae growth.
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Following usage of the pneumococcal conjugate vaccine
in children, the incidence of invasive pneumococcal dis-
ease (IPD) has declined in both children and adults
(reflecting herd immunity). Since our patient’s responsi-
ble serotype is included in all types of current S. pneu-
moniae vaccines, her life-threatening atypical bacterial
infection could have been avoided if the child had been
appropriately vaccinated. (Following the introduction of
heptavalent pneumococcal conjugate vaccine (PCV7),
the incidence rates of IPD caused by vaccine serotypes
declined across all age groups [3,4].)
Although atypical presentations of bacterial meningitis
still occur, emergency or community physicians are
rarely involved [5]. Only an atypical exanthema
(erythema nodosum) associated with meningitis (due to
Chlamydia pneumonia) has been reported in the litera-
ture [6]; to the best of our knowledge such an unusual
exanthema, presented in clusters of curvilinear skin
lesions and associated with severe pneumococcal infec-
tion, has never been described previously. Absence of
hemorrhagic rash has been recently reported as one of
the most significant clinical predictors of childhood
pneumococcal meningitis [7]. Regardless, such an atypi-
cal skin eruption, chronologically associated with cere-
bral vasculitis, has not been described in a child with
pneumococcal meningitis to date. However, a low CSF
glucose level, which was profoundly low (2 mg/dL) in
our patient, is an established significant risk factor for
hearing loss after pneumococcal meningitis [8,9].
As in our patient, in adult patients with meningoence-
phalitis caused by S. pneumoniae, diffusion-weighted
MRI may show lesions with restricted diffusion, reflect-
ing local areas of ischemia with cytotoxic edema second-
ary to immunologically mediated necrotizing vasculitis
and thrombosis [10]. Conventional angiography and
magnetic resonance angiography may show tapering and
stenosis of arteries [11]. Importantly, in a series in
adults, pneumococcal meningitis-associated arterial
(21.8%) or venous (9.2%) cerebrovascular complications
have been shown to develop more frequently than pre-
viously reported [12]. Other reported findings from the
same study were subarachnoid hemorrhages in associa-
tion with angiographic evidence of vasculitis (9.2%) and
acute spinal cord dysfunction due to myelitis (2.3%).
Delayed cerebral thrombosis has also been described in
adult patients with pneumococcal meningitis, with
pathology suggesting an immunological reaction target-
ing cerebral blood vessels [13].
S. pneumoniae bacteria do not readily penetrate the
pia and invade the brain. However, the interaction
between S. pneumoniae and the host results in menin-
geal inflammation, vascular injury, disruption of the
blood-brain barrier, vasogenic, interstitial and cytotoxic
edema, and disruption of normal CSF flow. Many of the
neurological and systemic conditions that contribute to
morbidity and mortality in pneumococcal meningitis, in
particular vascular injury and cerebral edema, have
already been set in motion by the time antibiotics are
administered. So even if antibiotic treatment is started
early and the bacteria are drug sensitive, as in our
patient’s case, unfavorable outcomes and severe neurolo-
gical sequelae of bacterial meningitis frequently still
occur. Treatment options to suppress the inflammatory
cascade causing neuronal injury include corticosteroids,
as they exert various immunomodulatory actions.
Although previously controversial, as steroids reduce
antibiotic penetration into the CSF, meta-analysis of
trial data now support treatment with a short course of
adjunctive therapy with the corticosteroid dexametha-
sone to improve outcome and partially prevent neurolo-
gical sequelae from bacterial meningitis in adults and
children [14]; this is however only achieved when given
e a r l yi nt h ed i s e a s ec o u r s ea n dw h e ns t a r t e dw i t ho r
before parenteral antibiotics [14]. It has been recently
suggested that dexamethasone inhibits increase of CSF
soluble tumor necrosis factor 1 levels after antibiotic
therapy in bacterial meningitis, an important indicator
of neurological sequelae in bacterial meningitis [15].
Conclusions
The interaction between S. pneumoniae bacteria and the
host results not only in meningeal inflammation but
also in vascular injury. Early administration of dexa-
methasone and empiric antibiotic treatment should
begin in all cases to prevent neurological sequel and
hearing loss associated with low CSF glucose levels.
Accordingly, the presence of an atypical rash should not
deter the physician from a clinical suspicion of this
potentially fatal pneumococcal infection. Brain MRI
scans and/or angiography, as well as CSF findings in
conjunction with the clinical course of this life-threaten-
ing disease, may dictate appropriate treatment adjust-
ments. Importantly, to the best of our knowledge, an
atypical skin eruption chronologically associated with
cerebral vasculitis has not been described previously.
However, with routine effective use of pneumococcal
conjugate vaccines a general decline in IPD, antibiotic
non-susceptibility and vaccine serotypes was observed.
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